Consistent with the whole-transcriptomic analysis, IBN-R and Dual-R MCL patient samples expressed significantly higher levels of MALT1 compared with IBN-S MCL patient samples (P < 0.001 and P < 0.01, respectively) (Figure 1E). This evidence concerns the gene MALT1 and mantle cell lymphoma.